A bipartisan Senate bill would cap insulin at $35 a month for people with private or employer-sponsored health insurance. Sen. Tim Kaine, who co-sponsored the measure, said it has cleared committee and now needs approval from the full Senate and the House. He called it a concrete way to lower health care costs for families.
